Abstract:Prediction of therapeutic peptide is a significant step for the discovery of promising therapeutic drugs. Most of the existing studies have focused on the mono-functional therapeutic peptide prediction. However, the number of multi-functional therapeutic peptides (MFTP) is growing rapidly, which requires new computational schemes to be proposed to facilitate MFTP discovery. In this study, based on multi-head self-attention mechanism and class weight optimization algorithm, we propose a novel model called PrMFTP for MFTP prediction. PrMFTP exploits multi-scale convolutional neural network, bi-directional long short-term memory, and multi-head self-attention mechanisms to fully extract and learn informative features of peptide sequence to predict MFTP. In addition, we design a class weight optimization scheme to address the problem of label imbalanced data. Comprehensive evaluation demonstrate that PrMFTP is superior to other state-of-the-art computational methods for predicting MFTP. We provide a user-friendly web server of PrMFTP, which is available at http://bioinfo.ahu.edu.cn/PrMFTP. Therapeutic peptides possess a wide range of biological properties, including anti-cancer, anti-hypertensive, anti-viral, and so forth. This is a prerequisite to understanding functional therapeutic peptides and ultimately designing these peptides for drug discovery and development. With the number of multi-functional therapeutic peptides (MFTP) growing, predicting these peptides is an urgent problem in the development of novel peptide-based therapeutics. We develope PrMFTP, an approach for MFTP prediction based on multi-label classification. Our method uses a deep neural network and multi-head self-attention that are able to optimize the features from the peptide sequences. Furthermore, for the imbalance problem in the multi-label dataset, a novel class weight optimization scheme is used to improve the performance of PrMFTP. We evaluate our approach using example-based measures and compare it with the top-performing MLBP method as well as the SOTA multi-functional peptides prediction approaches, demonstrating the improvement of PrMFTP over the existing methods.

Sequence homology score-based deep fuzzy network for identifying therapeutic peptides

Structured Sparse Regularized TSK Fuzzy System for Predicting Therapeutic Peptides

DeepTPpred: A Deep Learning Approach with Matrix Factorization for Predicting Therapeutic Peptides by Integrating Length Information

Subspace Projection-Based Weighted Echo State Networks for Predicting Therapeutic Peptides

Pep-CNN: an Improved Convolutional Neural Network for Predicting Therapeutic Peptides

HemoFuse: multi-feature fusion based on multi-head cross-attention for identification of hemolytic peptides

ITP-Pred: an interpretable method for predicting, therapeutic peptides with fused features low-dimension representation

Therapeutic peptides identification via kernel risk sensitive loss-based k-nearest neighbor model and multi-Laplacian regularization

Peptide-Major Histocompatibility Complex Class I Binding Prediction Based on Deep Learning with Novel Feature.

CSM‐peptides: A computational approach to rapid identification of therapeutic peptides

ACPNet: A Deep Learning Network to Identify Anticancer Peptides by Hybrid Sequence Information

Efficient prediction of anticancer peptides through deep learning

PrMFTP: Multi-functional therapeutic peptides prediction based on multi-head self-attention mechanism and class weight optimization

TPpred-SC: multi-functional therapeutic peptide prediction based on multi-label supervised contrastive learning

Anticancer peptides prediction with deep representation learning features

DeepSeqPan, a novel deep convolutional neural network model for pan-specific class I HLA-peptide binding affinity prediction

ACP-DL: A Deep Learning Long Short-Term Memory Model to Predict Anticancer Peptides Using High-Efficiency Feature Representation

Prediction of Hemolysis Tendency of Peptides using a Reliable Evaluation Method

Use of tree‐based machine learning methods to screen affinitive peptides based on docking data

AMHF‐TP: Multifunctional therapeutic peptides prediction based on multi‐granularity hierarchical features

DeepRescore: Leveraging Deep Learning to Improve Peptide Identification in Immunopeptidomics